353 related articles for article (PubMed ID: 15820194)
1. Sympathetic neuronal regulation of the heart in aging and heart failure.
Kaye D; Esler M
Cardiovasc Res; 2005 May; 66(2):256-64. PubMed ID: 15820194
[TBL] [Abstract][Full Text] [Related]
2. Cardiac sympathetic nerve terminal function in congestive heart failure.
Liang CS
Acta Pharmacol Sin; 2007 Jul; 28(7):921-7. PubMed ID: 17588326
[TBL] [Abstract][Full Text] [Related]
3. Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype.
Kaye DM; Smirk B; Finch S; Williams C; Esler MD
J Am Coll Cardiol; 2004 Nov; 44(10):2008-15. PubMed ID: 15542284
[TBL] [Abstract][Full Text] [Related]
4. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
[TBL] [Abstract][Full Text] [Related]
5. [The neurovegetative system in heart failure and heart transplantation].
Mortara A
Ital Heart J Suppl; 2001 Aug; 2(8):871-87. PubMed ID: 11582720
[TBL] [Abstract][Full Text] [Related]
6. Autonomic receptor systems in the failing and aging human heart: similarities and differences.
Brodde OE; Leineweber K
Eur J Pharmacol; 2004 Oct; 500(1-3):167-76. PubMed ID: 15464030
[TBL] [Abstract][Full Text] [Related]
7. The human sympathetic nervous system: its relevance in hypertension and heart failure.
Parati G; Esler M
Eur Heart J; 2012 May; 33(9):1058-66. PubMed ID: 22507981
[TBL] [Abstract][Full Text] [Related]
8. Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder.
Esler M; Eikelis N; Schlaich M; Lambert G; Alvarenga M; Kaye D; El-Osta A; Guo L; Barton D; Pier C; Brenchley C; Dawood T; Jennings G; Lambert E
Ann N Y Acad Sci; 2008 Dec; 1148():338-48. PubMed ID: 19120127
[TBL] [Abstract][Full Text] [Related]
9. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.
Lambert GW; Kaye DM; Lefkovits J; Jennings GL; Turner AG; Cox HS; Esler MD
Circulation; 1995 Oct; 92(7):1813-8. PubMed ID: 7545554
[TBL] [Abstract][Full Text] [Related]
10. The sympathetic nervous system in heart failure.
Cohn JN
J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S57-61. PubMed ID: 2478811
[TBL] [Abstract][Full Text] [Related]
11. Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation.
Despas F; Detis N; Dumonteil N; Labrunee M; Bellon B; Franchitto N; Galinier M; Senard JM; Pathak A
J Hypertens; 2009 Sep; 27(9):1849-54. PubMed ID: 19542895
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of cardiac neurotrophic factors and sympathetic nerve ending abnormalities within the failing heart.
Kreusser MM; Buss SJ; Krebs J; Kinscherf R; Metz J; Katus HA; Haass M; Backs J
J Mol Cell Cardiol; 2008 Feb; 44(2):380-7. PubMed ID: 18037433
[TBL] [Abstract][Full Text] [Related]
13. [Adreno-sympathetic activity and congestive cardiac insufficiency].
Valori C; Renzini V; Brunori CA; Porcellati C; Corea L; Petz E; Muiesan G
Cuore Circ; 1968 Dec; 52(6):285-306. PubMed ID: 5710403
[No Abstract] [Full Text] [Related]
14. beta-Blocker therapy for congestive heart failure: clinical considerations.
Kamath SA; Yancy CW
Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):12-20. PubMed ID: 19667706
[TBL] [Abstract][Full Text] [Related]
15. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.
Esler M; Lambert G; Brunner-La Rocca HP; Vaddadi G; Kaye D
Acta Physiol Scand; 2003 Mar; 177(3):275-84. PubMed ID: 12608997
[TBL] [Abstract][Full Text] [Related]
16. Myocardial catecholamines and the pathophysiology of heart failure.
Daly PA; Sole MJ
Circulation; 1990 Aug; 82(2 Suppl):I35-43. PubMed ID: 2197023
[TBL] [Abstract][Full Text] [Related]
17. The sympathetic nervous system and pathophysiology of congestive heart failure.
Farmer J
Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):6-11. PubMed ID: 19667705
[TBL] [Abstract][Full Text] [Related]
18. [Sympathetic nervous system in heart failure: effect of catecholamines and nitric oxide].
Drexler H
Z Kardiol; 1996; 85 Suppl 6():247-52. PubMed ID: 9064972
[TBL] [Abstract][Full Text] [Related]
19. Influence of central inhibition of sympathetic nervous activity on myocardial metabolism in chronic heart failure: acute effects of the imidazoline I1-receptor agonist moxonidine.
Mobini R; Fu M; Jansson PA; Bergh CH; Scharin Täng M; Waagstein F; Andersson B
Clin Sci (Lond); 2006 Mar; 110(3):329-36. PubMed ID: 16209659
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of cardiac dysfunction in congestive heart failure.
Dhalla NS; Afzal N; Beamish RE; Naimark B; Takeda N; Nagano M
Can J Cardiol; 1993 Dec; 9(10):873-87. PubMed ID: 8281476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
